End-of-dose emergent psychopathology in ambulatory patients with epilepsy on stable-dose lamotrigine monotherapy: A case series of six patients

Epilepsy and Behavior

Volumn 15, Issue 4, 2009, Pages 521-523

  Frey, Lauren C ^a,b   Strom, Laura A ^a   Shrestha, Archana ^a   Spitz, Mark C ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Colorado Injury Control and Research Center ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adverse effects; Lamotrigine; Withdrawal

Indexed keywords

ALPRAZOLAM; CITALOPRAM; CLONAZEPAM; CYCLOBENZAPRINE; LAMOTRIGINE; LORAZEPAM; OXYCODONE; RISPERIDONE; ZOLPIDEM;

ADULT; ANXIETY; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; DEPRESSION; DISTRESS SYNDROME; EPILEPSY; EVENING DOSAGE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; IRRITABILITY; LONG TERM CARE; MALE; MENTAL INSTABILITY; MORNING DOSAGE; OUTPATIENT; SIMPLE PARTIAL SEIZURE; TONIC CLONIC SEIZURE; WITHDRAWAL SYNDROME;

ADULT; AFFECTIVE SYMPTOMS; AGORAPHOBIA; ANTICONVULSANTS; BIPOLAR DISORDER; DEPRESSION; EPILEPSY; FEMALE; HUMANS; IRRITABLE MOOD; MALE; MENTAL DISORDERS; MIDDLE AGED; SEIZURES; TRIAZINES; YOUNG ADULT;

EID: 67849109639     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.05.008     Document Type: Article

References (17)

1. Lazarou J., Pomerantz B.H., and Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (1998) 1200-1205
2. Gelisse P., Kissani N., Crespel A., Jafari H., and Baldy-Mouliner M. Is there a lamotrigine withdrawal syndrome?. Acta Neurol Scand 105 (2002) 232-234
3. Lejoyeux M., and Ades J. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 58 Suppl. 7 (1997) 11-16
4. Duncan J.S., Shorvon S.D., and Trimble M.R. Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate. J Neurol Neurosurg Psychiatry 51 (1988) 924-928
5. Fava M. Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry 67 Suppl. 4 (2006) 14-21
6. Ketter T.A., Malow B.A., Flamini R., White S.R., Post R.M., and Theodore W.H. Anticonvulsant withdrawal-emergent psychopathology. Neurology 44 (1994) 55-61
7. Demers-Desrosiers L.A., Nestoros J.N., and Vaillancourt P. Acute psychosis precipitated by withdrawal of anticonvulsant medication. Am J Psychiatry 135 (1978) 981-982
8. Rosenblum J.A. Diphenylhydantoin sodium (Dilantin) withdrawal in non-epileptic patients. Curr Ther Res Clin Exp 13 (1971) 369-373
9. Meador K.J., and Baker G.A. Behavioral and cognitive effects of lamotrigine. J Child Neurol 12 Suppl. 1 (1997) S44-S47
10. Meador K.J., Loring D.W., Vahle V.J., et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 64 (2005) 2108-2114
11. Geddes J.R., Calabrese J.R., and Goodwin G.M. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194 (2009) 4-9
12. Almeida A.M., Falcao A.C., Sales F., Baldeiras I., Rocha M.J., and Caramona M.M. Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring. Eur J Clin Pharmacol 62 (2006) 737-742
13. Ramsay R.E., Pellock J.M., Garnett W.R., et al. Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy. Epilepsy Res 10 (1991) 191-200
14. Nielsen K.A., Dahl M., Tommerup E., Hansen B.R., Erdal J., and Wolf P. Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration. Epilepsy Behav 13 (2008) 470-473
15. Dilsaver S.C., Greden J.F., and Snider R.M. Antidepressant withdrawal syndromes: phenomenology and pathophysiology. Int Clin Psychopharmacol 2 (1987) 1-19
16. Halle M.T., and Dilsaver S.C. Tranylcypromine withdrawal phenomena. J Psychiatry Neurosci 18 (1993) 49-50
17. Sironi V.A., Franzini A., Ravagnati L., and Marossero F. Interictal acute psychoses in temporal lobe epilepsy during withdrawal of anticonvulsant therapy. J Neurol Neurosurg Psychiatry 42 (1979) 724-730